| __timestamp | Arrowhead Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 382096000000 |
| Thursday, January 1, 2015 | 57410147 | 345927000000 |
| Friday, January 1, 2016 | 41454452 | 312303000000 |
| Sunday, January 1, 2017 | 31690298 | 325441000000 |
| Monday, January 1, 2018 | 52968505 | 368298000000 |
| Tuesday, January 1, 2019 | 81048686 | 492381000000 |
| Wednesday, January 1, 2020 | 128874979 | 455833000000 |
| Friday, January 1, 2021 | 206342000 | 526087000000 |
| Saturday, January 1, 2022 | 297307000 | 633325000000 |
| Sunday, January 1, 2023 | 353188000 | 729924000000 |
| Monday, January 1, 2024 | 505870000 | 729924000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, Takeda Pharmaceutical Company Limited and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures.
From 2014 to 2024, Takeda's R&D spending has consistently dwarfed that of Arrowhead, with Takeda investing nearly 1,500 times more in 2023 alone. This substantial investment reflects Takeda's commitment to maintaining its position as a global leader in the pharmaceutical industry. Meanwhile, Arrowhead has shown a remarkable growth trajectory, increasing its R&D spending by over 2,000% from 2014 to 2024, signaling its aggressive push into the biotech space.
These trends highlight the diverse approaches companies take in the pharmaceutical sector, balancing between large-scale investment and strategic growth to drive innovation and market presence.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.